{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:15:48Z","timestamp":1790014548025,"version":"4.0.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2018.00847","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T05:30:53Z","timestamp":1542173453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia"],"prefix":"10.3389","volume":"12","author":[{"given":"Woojin Scott","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry-Anne","family":"Rye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1001\/jamaneurol.2014.1931","article-title":"Quantifying the eating abnormalities in frontotemporal dementia.","volume":"71","author":"Ahmed","year":"","journal-title":"JAMA Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1212\/WNL.0000000000000993","article-title":"Systemic metabolism in frontotemporal dementia.","volume":"83","author":"Ahmed","year":"","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1177\/1533317514539541","article-title":"Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer\u2019s disease and vascular dementia.","volume":"29","author":"Alam","year":"2014","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"B4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ahj.2015.12.022","article-title":"Genetic loci associated with ideal cardiovascular health: a meta-analysis of genome-wide association studies.","volume":"175","author":"Allen","year":"2016","journal-title":"Am. Heart J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.","volume":"121","author":"Besler","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1212\/01.WNL.0000052685.09194.39","article-title":"Staging disease severity in pathologically confirmed cases of frontotemporal dementia.","volume":"60","author":"Broe","year":"2003","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/srep36155","article-title":"Performance metrics for selecting single nucleotide polymorphisms in late-onset Alzheimer\u2019s disease.","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"38108","DOI":"10.1074\/jbc.M504678200","article-title":"Molecular mechanism of the blockade of plasma cholesteryl ester transfer protein by its physiological inhibitor apolipoprotein CI.","volume":"280","author":"Dumont","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease.","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0009-9120(94)90035-3","article-title":"Immunoturbidimetry of serum apolipoproteins A-I and B on the Cobas bio centrifugal analyzer: method validation and reference values.","volume":"27","author":"Eugui","year":"1994","journal-title":"Clin. Biochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.1074\/jbc.273.11.6088","article-title":"Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.","volume":"273","author":"Garner","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.neurobiolaging.2005.03.011","article-title":"Differences in regional brain atrophy in genetic forms of Alzheimer\u2019s disease.","volume":"27","author":"Gregory","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","article-title":"HDL and cognition in neurodegenerative disorders.","volume":"72","author":"Hottman","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jnnp.73.4.371","article-title":"Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer\u2019s disease.","volume":"73","author":"Ikeda","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002907","article-title":"Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis.","volume":"8","author":"Inouye","year":"2012","journal-title":"PLoS Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1046\/j.1471-4159.1995.64020895.x","article-title":"Cholesterol for synthesis of myelin is made locally, not imported into brain.","volume":"64","author":"Jurevics","year":"1995","journal-title":"J. Neurochem."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00104","article-title":"Lipidomics analysis of behavioral variant frontotemporal dementia: a scope for biomarker development.","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1096\/fj.00-0815fje","article-title":"Essential role for cholesterol in synaptic plasticity and neuronal degeneration.","volume":"15","author":"Koudinov","year":"2001","journal-title":"FASEB J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000077161","article-title":"Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy.","volume":"17","author":"Kril","year":"2004","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jns.2005.02.003","article-title":"Distribution of brain atrophy in behavioral variant frontotemporal dementia.","volume":"232","author":"Kril","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1111\/j.1460-9568.2009.06983.x","article-title":"Involvement of paraoxonase 1 genetic variants in Alzheimer\u2019s disease neuropathology.","volume":"30","author":"Leduc","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00109-003-0481-4","article-title":"Paraoxonase gene polymorphisms, oxidative stress, and diseases.","volume":"81","author":"Li","year":"2003","journal-title":"J. Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/j.1464-5491.2008.02546.x","article-title":"Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides.","volume":"25","author":"Mastorikou","year":"2008","journal-title":"Diabet. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol.","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1001\/jama.2011.810","article-title":"Changing concepts of Alzheimer disease.","volume":"305","author":"McKhann","year":"2011","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","article-title":"Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.","volume":"372","author":"McQueen","year":"2008","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.","volume":"1","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/brain\/awx066","article-title":"Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia.","volume":"140","author":"Mishra","year":"2017","journal-title":"Brain"},{"key":"B30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijcard.2003.05.011","article-title":"PON1 M\/L55 mutation protects high-risk patients against coronary artery disease.","volume":"94","author":"Oliveira","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neulet.2012.06.071","article-title":"Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer\u2019s disease: a meta-analysis.","volume":"523","author":"Pi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(10)70299-4","article-title":"Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management.","volume":"10","author":"Piguet","year":"2011","journal-title":"Lancet Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3233\/JAD-2012-120403","article-title":"TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia.","volume":"31","author":"Seripa","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1194\/jlr.R035725","article-title":"Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.","volume":"54","author":"Shah","year":"2013","journal-title":"J. Lipid Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid.","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(03)12663-3","article-title":"Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.","volume":"361","author":"Sniderman","year":"2003","journal-title":"Lancet"},{"key":"B38","first-page":"29","article-title":"A practical enzymatic cholesterol determination.","volume":"30","author":"Stahler","year":"1977","journal-title":"Med. Lab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3109\/17482960802455416","article-title":"Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review.","volume":"10","author":"Sutedja","year":"2009","journal-title":"Amyotroph Lateral Scler."},{"key":"B40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0009-8981(77)90465-X","article-title":"A new enzymatic method for determination of serum choline-containing phospholipids.","volume":"79","author":"Takayama","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"B41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ana.21993","article-title":"Paraoxonase gene mutations in amyotrophic lateral sclerosis.","volume":"68","author":"Ticozzi","year":"2010","journal-title":"Ann. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy\u2013a review of the evidence.","volume":"259","author":"Walldius","year":"2006","journal-title":"J. Intern. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1161\/ATVBAHA.109.194555","article-title":"HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.","volume":"29","author":"Zerrad-Saadi","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087017","article-title":"Association between APOC1 polymorphism and Alzheimer\u2019s disease: a case-control study and meta-analysis.","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2018.00847\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T05:30:56Z","timestamp":1542173456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2018.00847\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":44,"alternative-id":["10.3389\/fnins.2018.00847"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2018.00847","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"article-number":"847"}}